TERNS
LIVE

Serial Number

98740258

Owner

Terns Pharmaceuticals, Inc.

Attorney

Tiffany D. Gehrke

Filing Date

Sep 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TERNS Trademark

Serial Number: 98740258

TERNS is a trademark filed by Terns Pharmaceuticals, Inc. on September 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Terns Pharmaceuticals, Inc. (3 trademarks)

1065 East Hillsdale Blvd., Suite 100
Foster City, CA 94404

Entity Type: 03

Trademark Details

Filing Date

September 9, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; Research and development services in the field of pharmaceutical and biologic preparations; Research and development services in the field of oncology-related diseases and disorders; Research and development services in the field of metabolic-related diseases and disorders; Research and development services in the field of endocrine-related diseases and disorders; Research and development services in the fields of diabetes and obesity-related diseases and disorders; Research and development services in the field of peptide pharmaceutical preparations; Providing medical and scientific research information in the field of small-molecule drugs; Providing medical and scientific research information in the field of clinical trials and post-market trials; Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.

Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 25, 2026 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 24, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 24, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 24, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2025 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2024 NWOS
NEW APPLICATION ENTERED
Sep 9, 2024 NWAP